SCOPUS 정보 검색 플랫폼

British Journal of Clinical Pharmacology

Volumn 42, Issue 4, 1996, Pages 525-527

Mercaptopurine in childhood leukaemia: The effects of dose escalation on thioguanine nucleotide metabolites

(3) Lennard, L a,c Welch, J a Lilleyman, J S b

a UNIVERSITY OF SHEFFIELD (United Kingdom)

b ST BARTHOLOMEW S HOSPITAL (United Kingdom)

c ROYAL HALLAMSHIRE HOSPITAL (United Kingdom)

Author keywords

childhood leukaemia; compliance; mercaptopurine; thioguanine nucleotides

Indexed keywords

DRUG METABOLITE; MERCAPTOPURINE; TIOGUANINE;

ARTICLE; CANCER CHEMOTHERAPY; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOPENIA; DRUG METABOLISM; ERYTHROCYTE; FEMALE; HUMAN; LYMPHATIC LEUKEMIA; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0029819309 PISSN: 03065251 EISSN: None Source Type: Journal
DOI: 10.1111/j.1365-2125.1996.tb00021.x Document Type: Article

Times cited : (8)

References (6)

1
- 0028269944
- Mercaptopurine metabolism and risk of relapse in childhood lymphoblastic leukaemia
- Lilleyman JS, Lennard L. Mercaptopurine metabolism and risk of relapse in childhood lymphoblastic leukaemia. Lancet 1994; 343: 1188-1190.
- (1994) Lancet , vol.343 , pp. 1188-1190
- Lilleyman, J.S.¹ Lennard, L.²

2
- 0025331198
- Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia
- Lennard L, Lilleyman JS, Van Loon J, Weinshilboum RM. Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia. Lancet 1990; 336: 225-229.
- (1990) Lancet , vol.336 , pp. 225-229
- Lennard, L.¹ Lilleyman, J.S.² Van Loon, J.³ Weinshilboum, R.M.⁴

3
- 0028813641
- Intensification of treatment improves survival for all children with lymphoblastic leukaemia: Results of MRC UKALL X
- Chessells JM, Bailey CC, Richards SM. Intensification of treatment improves survival for all children with lymphoblastic leukaemia: results of MRC UKALL X. Lancet 1995; 345: 143-148.
- (1995) Lancet , vol.345 , pp. 143-148
- Chessells, J.M.¹ Bailey, C.C.² Richards, S.M.³

4
- 0029931874
- 6-Mercaptopurine dose escalation and its effect on drug tolerance in childhood lymphoblastic leukaemia
- Welch JC, Lilleyman JS. 6-Mercaptopurine dose escalation and its effect on drug tolerance in childhood lymphoblastic leukaemia. Cancer Chemother Pharmacol 1996; 38: 113-116.
- (1996) Cancer Chemother Pharmacol , vol.38 , pp. 113-116
- Welch, J.C.¹ Lilleyman, J.S.²

5
- 0026465403
- High-performance liquid chromatographic assay of the methyl and nucleotide metabolites of 6-mercaptopurine: Quantification of red blood cell 6-thioguanine nucleotide, 6-thioinosinic acid and 6-methylmercaptopurine metabolites in a single sample
- Lennard L, Singleton HJ. High-performance liquid chromatographic assay of the methyl and nucleotide metabolites of 6-mercaptopurine: quantification of red blood cell 6-thioguanine nucleotide, 6-thioinosinic acid and 6-methylmercaptopurine metabolites in a single sample. J Chromatogr 1992; 583; 83-90.
- (1992) J Chromatogr , vol.583 , pp. 83-90
- Lennard, L.¹ Singleton, H.J.²

6
- 0026058790
- Maintenance chemotherapy and cure of childhood acute lymphoblastic leukaemia
- Gale RP, Butturini A. Maintenance chemotherapy and cure of childhood acute lymphoblastic leukaemia. Lancet 1991; 383: 1315-1318.
- (1991) Lancet , vol.383 , pp. 1315-1318
- Gale, R.P.¹ Butturini, A.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.